Investing.com - Gilead (NASDAQ:GILD) reported on Tuesday fourth quarter earnings that missed analysts' forecasts and revenue that topped expectations.
Gilead announced earnings per share of $0.69 on revenue of $7.24B. Analysts polled by Investing.com anticipated EPS of $1.58 on revenue of $6.6B.
Gilead shares are down 5% from the beginning of the year and are trading at $65.91 , down-from-52-week-high.They are outperforming the Nasdaq 100 which is down 7.97% from the start of the year.
Gilead shares lost 3.74% in after-hours trade the report.
Gilead follows other major Healthcare sector earnings this month
Gilead's report follows an earnings beat by J&J on January 25, who reported EPS of $2.13 on revenue of $24.8B, compared to forecasts EPS of $2.12 on revenue of $25.28B.
UnitedHealth had beat expectations on January 19 with fourth quarter EPS of $4.48 on revenue of $73.74B, compared to forecast for EPS of $4.3 on revenue of $72.98B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar